VCYT Stock Analysis: Buy, Sell, or Hold?
VCYT - Veracyte, Inc.
$56.97
-2.33 (-3.93%)
▼
5d:
-0.19%
30d:
+15.7%
90d:
+81.72%
HOLD
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When VCYT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VCYT trades at premium valuation expecting 8.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: VCYT trades at premium valuation expecting 8.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$55.67
Based on 4.3% avg growth
INTRINSIC VALUE TODAY
$34.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VCYT is currently trading at $56.97, which is considered slightly high relative to its 30-day fair value range of $48.36 to $57.54. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.8) compared to its historical average (23.6). At these levels, the market is pricing in 8.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, VCYT is in a strong uptrend. Immediate support is located at $54.25, while resistance sits at $60.91. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VCYT is in a strong uptrend. Immediate support is located at $54.25, while resistance sits at $60.91. Short-term momentum is weak, with the stock down 3.9% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$48.36 -
$57.54
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
53.3%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.9%)
- BEARISH: Trading above Wall St target ($52.80)
- NEUTRAL: PE elevated vs history but 8.1% growth expectation is conservative given 289% recent growth
Trading Range Analysis
30-Day Trading Range
$48.36 -
$57.54
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$54.25
Resistance Level
$60.91
Current Trend
Strong Uptrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
29.81
Wall Street Target
$52.80
(-7.3%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
288.9%
Profit Margin
16.2%
Valuation Premium vs History
+8.1% premium
PE vs Historical
29.8 vs 23.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.1%
(market-implied from PE analysis)
1-Year Target
$61.58
(+8%)
2-Year Target
$66.57
(+17%)
3-Year Target
$71.97
(+26%)
3-Yr Target (if PE normalizes)
(PE: 30→24)
PE COMPRESSION
$56.97
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.8, Growth: 4.6%)
$65.19
(+14%)
Base:
(SPY PE: 21.8, Growth: 4.6%)
$47.63
(-16%)
Bear:
(PE: 18.5, Growth: 4.6%)
$40.49
(-29%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (33x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Forward PE: 32.68 | Forward EPS (Implied): $1.74
Bull Case
$68.79
(+21%)
Analyst growth 15.0%, PE expands to 34.3
Base Case
$56.97
(0%)
Market implied 0.0%, PE stable at 32.7
Bear Case
$43.58
(-24%)
Severe decline -15.0%, PE contracts to 29.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 4:17 AM ET
Data refreshes hourly during market hours. Next update: 5:17 AM
Data refreshes hourly during market hours. Next update: 5:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VCYT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
John Leite
SELL
5260 shares
2026-03-04
Marc Stapley
SELL
45523 shares
2026-03-04
Rebecca Chambers
SELL
18341 shares
2026-03-04
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 65 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 62 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 63 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 59 HOLD |
